nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—CYP2C19—Memantine—Alzheimer's disease	0.13	0.28	CbGbCtD
Aprepitant—CYP2C9—Donepezil—Alzheimer's disease	0.125	0.268	CbGbCtD
Aprepitant—CYP3A4—Rivastigmine—Alzheimer's disease	0.0908	0.195	CbGbCtD
Aprepitant—CYP3A4—Donepezil—Alzheimer's disease	0.0726	0.156	CbGbCtD
Aprepitant—CYP3A4—Galantamine—Alzheimer's disease	0.0468	0.101	CbGbCtD
Aprepitant—TACR3—forebrain—Alzheimer's disease	0.0104	0.188	CbGeAlD
Aprepitant—TACR3—telencephalon—Alzheimer's disease	0.00955	0.173	CbGeAlD
Aprepitant—TACR3—nervous system—Alzheimer's disease	0.00564	0.102	CbGeAlD
Aprepitant—TACR3—central nervous system—Alzheimer's disease	0.00543	0.0982	CbGeAlD
Aprepitant—TACR3—cerebellum—Alzheimer's disease	0.0053	0.096	CbGeAlD
Aprepitant—TACR3—brain—Alzheimer's disease	0.00431	0.078	CbGeAlD
Aprepitant—TACR1—forebrain—Alzheimer's disease	0.00402	0.0728	CbGeAlD
Aprepitant—TACR1—telencephalon—Alzheimer's disease	0.0037	0.0669	CbGeAlD
Aprepitant—TACR1—nervous system—Alzheimer's disease	0.00218	0.0395	CbGeAlD
Aprepitant—TACR1—central nervous system—Alzheimer's disease	0.0021	0.038	CbGeAlD
Aprepitant—TACR1—brain—Alzheimer's disease	0.00167	0.0302	CbGeAlD
Aprepitant—Chest pain—Galantamine—Alzheimer's disease	0.000586	0.00168	CcSEcCtD
Aprepitant—Myalgia—Galantamine—Alzheimer's disease	0.000586	0.00168	CcSEcCtD
Aprepitant—Anxiety—Galantamine—Alzheimer's disease	0.000584	0.00167	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000582	0.00167	CcSEcCtD
Aprepitant—Discomfort—Galantamine—Alzheimer's disease	0.000579	0.00166	CcSEcCtD
Aprepitant—Haematuria—Rivastigmine—Alzheimer's disease	0.000578	0.00165	CcSEcCtD
Aprepitant—Dry mouth—Galantamine—Alzheimer's disease	0.000573	0.00164	CcSEcCtD
Aprepitant—Tinnitus—Donepezil—Alzheimer's disease	0.000572	0.00164	CcSEcCtD
Aprepitant—Confusional state—Galantamine—Alzheimer's disease	0.000567	0.00162	CcSEcCtD
Aprepitant—Bradycardia—Memantine—Alzheimer's disease	0.000567	0.00162	CcSEcCtD
Aprepitant—Bradycardia—Rivastigmine—Alzheimer's disease	0.000554	0.00159	CcSEcCtD
Aprepitant—Hypoaesthesia—Memantine—Alzheimer's disease	0.000554	0.00158	CcSEcCtD
Aprepitant—Hallucination—Memantine—Alzheimer's disease	0.000554	0.00158	CcSEcCtD
Aprepitant—Shock—Galantamine—Alzheimer's disease	0.000553	0.00158	CcSEcCtD
Aprepitant—Pharyngitis—Memantine—Alzheimer's disease	0.000552	0.00158	CcSEcCtD
Aprepitant—Nervous system disorder—Galantamine—Alzheimer's disease	0.000551	0.00158	CcSEcCtD
Aprepitant—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00055	0.00157	CcSEcCtD
Aprepitant—Chills—Donepezil—Alzheimer's disease	0.00055	0.00157	CcSEcCtD
Aprepitant—Urinary tract disorder—Memantine—Alzheimer's disease	0.00055	0.00157	CcSEcCtD
Aprepitant—Tachycardia—Galantamine—Alzheimer's disease	0.000549	0.00157	CcSEcCtD
Aprepitant—Connective tissue disorder—Memantine—Alzheimer's disease	0.000547	0.00156	CcSEcCtD
Aprepitant—Skin disorder—Galantamine—Alzheimer's disease	0.000546	0.00156	CcSEcCtD
Aprepitant—Urethral disorder—Memantine—Alzheimer's disease	0.000546	0.00156	CcSEcCtD
Aprepitant—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000543	0.00155	CcSEcCtD
Aprepitant—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000542	0.00155	CcSEcCtD
Aprepitant—Hallucination—Rivastigmine—Alzheimer's disease	0.000542	0.00155	CcSEcCtD
Aprepitant—Alopecia—Donepezil—Alzheimer's disease	0.000542	0.00155	CcSEcCtD
Aprepitant—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00054	0.00155	CcSEcCtD
Aprepitant—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000538	0.00154	CcSEcCtD
Aprepitant—Mental disorder—Donepezil—Alzheimer's disease	0.000537	0.00154	CcSEcCtD
Aprepitant—Anorexia—Galantamine—Alzheimer's disease	0.000536	0.00153	CcSEcCtD
Aprepitant—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000535	0.00153	CcSEcCtD
Aprepitant—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000534	0.00153	CcSEcCtD
Aprepitant—Malnutrition—Donepezil—Alzheimer's disease	0.000534	0.00153	CcSEcCtD
Aprepitant—Erythema—Donepezil—Alzheimer's disease	0.000534	0.00153	CcSEcCtD
Aprepitant—Erythema multiforme—Memantine—Alzheimer's disease	0.000526	0.00151	CcSEcCtD
Aprepitant—Flatulence—Donepezil—Alzheimer's disease	0.000526	0.0015	CcSEcCtD
Aprepitant—Hypotension—Galantamine—Alzheimer's disease	0.000525	0.0015	CcSEcCtD
Aprepitant—Dysgeusia—Donepezil—Alzheimer's disease	0.000523	0.0015	CcSEcCtD
Aprepitant—Eye disorder—Memantine—Alzheimer's disease	0.00052	0.00149	CcSEcCtD
Aprepitant—Tinnitus—Memantine—Alzheimer's disease	0.000519	0.00148	CcSEcCtD
Aprepitant—Cardiac disorder—Memantine—Alzheimer's disease	0.000517	0.00148	CcSEcCtD
Aprepitant—Flushing—Memantine—Alzheimer's disease	0.000517	0.00148	CcSEcCtD
Aprepitant—Back pain—Donepezil—Alzheimer's disease	0.000516	0.00148	CcSEcCtD
Aprepitant—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000515	0.00147	CcSEcCtD
Aprepitant—Muscle spasms—Donepezil—Alzheimer's disease	0.000513	0.00147	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000512	0.00146	CcSEcCtD
Aprepitant—Eye disorder—Rivastigmine—Alzheimer's disease	0.000509	0.00146	CcSEcCtD
Aprepitant—Insomnia—Galantamine—Alzheimer's disease	0.000508	0.00145	CcSEcCtD
Aprepitant—Tinnitus—Rivastigmine—Alzheimer's disease	0.000508	0.00145	CcSEcCtD
Aprepitant—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000505	0.00145	CcSEcCtD
Aprepitant—Flushing—Rivastigmine—Alzheimer's disease	0.000505	0.00145	CcSEcCtD
Aprepitant—Angiopathy—Memantine—Alzheimer's disease	0.000505	0.00144	CcSEcCtD
Aprepitant—Paraesthesia—Galantamine—Alzheimer's disease	0.000505	0.00144	CcSEcCtD
Aprepitant—Immune system disorder—Memantine—Alzheimer's disease	0.000503	0.00144	CcSEcCtD
Aprepitant—Mediastinal disorder—Memantine—Alzheimer's disease	0.000502	0.00144	CcSEcCtD
Aprepitant—Tremor—Donepezil—Alzheimer's disease	0.0005	0.00143	CcSEcCtD
Aprepitant—Somnolence—Galantamine—Alzheimer's disease	0.0005	0.00143	CcSEcCtD
Aprepitant—Chills—Memantine—Alzheimer's disease	0.000499	0.00143	CcSEcCtD
Aprepitant—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000495	0.00142	CcSEcCtD
Aprepitant—Dyspepsia—Galantamine—Alzheimer's disease	0.000495	0.00142	CcSEcCtD
Aprepitant—Angiopathy—Rivastigmine—Alzheimer's disease	0.000494	0.00141	CcSEcCtD
Aprepitant—Anaemia—Donepezil—Alzheimer's disease	0.000493	0.00141	CcSEcCtD
Aprepitant—CYP3A4—nervous system—Alzheimer's disease	0.000493	0.00892	CbGeAlD
Aprepitant—Alopecia—Memantine—Alzheimer's disease	0.000492	0.00141	CcSEcCtD
Aprepitant—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000491	0.0014	CcSEcCtD
Aprepitant—Chills—Rivastigmine—Alzheimer's disease	0.000489	0.0014	CcSEcCtD
Aprepitant—Decreased appetite—Galantamine—Alzheimer's disease	0.000489	0.0014	CcSEcCtD
Aprepitant—Mental disorder—Memantine—Alzheimer's disease	0.000488	0.0014	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000485	0.00139	CcSEcCtD
Aprepitant—Malnutrition—Memantine—Alzheimer's disease	0.000485	0.00139	CcSEcCtD
Aprepitant—Fatigue—Galantamine—Alzheimer's disease	0.000485	0.00139	CcSEcCtD
Aprepitant—Malaise—Donepezil—Alzheimer's disease	0.000481	0.00138	CcSEcCtD
Aprepitant—Alopecia—Rivastigmine—Alzheimer's disease	0.000481	0.00138	CcSEcCtD
Aprepitant—Constipation—Galantamine—Alzheimer's disease	0.000481	0.00138	CcSEcCtD
Aprepitant—Syncope—Donepezil—Alzheimer's disease	0.000479	0.00137	CcSEcCtD
Aprepitant—Flatulence—Memantine—Alzheimer's disease	0.000477	0.00137	CcSEcCtD
Aprepitant—Mental disorder—Rivastigmine—Alzheimer's disease	0.000477	0.00136	CcSEcCtD
Aprepitant—Dysgeusia—Memantine—Alzheimer's disease	0.000475	0.00136	CcSEcCtD
Aprepitant—CYP3A4—central nervous system—Alzheimer's disease	0.000474	0.00859	CbGeAlD
Aprepitant—Erythema—Rivastigmine—Alzheimer's disease	0.000474	0.00136	CcSEcCtD
Aprepitant—Malnutrition—Rivastigmine—Alzheimer's disease	0.000474	0.00136	CcSEcCtD
Aprepitant—Loss of consciousness—Donepezil—Alzheimer's disease	0.000469	0.00134	CcSEcCtD
Aprepitant—Back pain—Memantine—Alzheimer's disease	0.000469	0.00134	CcSEcCtD
Aprepitant—Flatulence—Rivastigmine—Alzheimer's disease	0.000467	0.00134	CcSEcCtD
Aprepitant—Cough—Donepezil—Alzheimer's disease	0.000466	0.00133	CcSEcCtD
Aprepitant—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000464	0.00133	CcSEcCtD
Aprepitant—Feeling abnormal—Galantamine—Alzheimer's disease	0.000463	0.00133	CcSEcCtD
Aprepitant—Convulsion—Donepezil—Alzheimer's disease	0.000462	0.00132	CcSEcCtD
Aprepitant—Hypertension—Donepezil—Alzheimer's disease	0.000461	0.00132	CcSEcCtD
Aprepitant—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00046	0.00131	CcSEcCtD
Aprepitant—Back pain—Rivastigmine—Alzheimer's disease	0.000459	0.00131	CcSEcCtD
Aprepitant—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000456	0.0013	CcSEcCtD
Aprepitant—Arthralgia—Donepezil—Alzheimer's disease	0.000454	0.0013	CcSEcCtD
Aprepitant—Chest pain—Donepezil—Alzheimer's disease	0.000454	0.0013	CcSEcCtD
Aprepitant—Myalgia—Donepezil—Alzheimer's disease	0.000454	0.0013	CcSEcCtD
Aprepitant—Tremor—Memantine—Alzheimer's disease	0.000454	0.0013	CcSEcCtD
Aprepitant—Anxiety—Donepezil—Alzheimer's disease	0.000453	0.0013	CcSEcCtD
Aprepitant—Ill-defined disorder—Memantine—Alzheimer's disease	0.00045	0.00129	CcSEcCtD
Aprepitant—Discomfort—Donepezil—Alzheimer's disease	0.000449	0.00128	CcSEcCtD
Aprepitant—Anaemia—Memantine—Alzheimer's disease	0.000448	0.00128	CcSEcCtD
Aprepitant—Dry mouth—Donepezil—Alzheimer's disease	0.000444	0.00127	CcSEcCtD
Aprepitant—Body temperature increased—Galantamine—Alzheimer's disease	0.000444	0.00127	CcSEcCtD
Aprepitant—Abdominal pain—Galantamine—Alzheimer's disease	0.000444	0.00127	CcSEcCtD
Aprepitant—Tremor—Rivastigmine—Alzheimer's disease	0.000444	0.00127	CcSEcCtD
Aprepitant—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00044	0.00126	CcSEcCtD
Aprepitant—Confusional state—Donepezil—Alzheimer's disease	0.000439	0.00126	CcSEcCtD
Aprepitant—Anaemia—Rivastigmine—Alzheimer's disease	0.000438	0.00125	CcSEcCtD
Aprepitant—Malaise—Memantine—Alzheimer's disease	0.000437	0.00125	CcSEcCtD
Aprepitant—Oedema—Donepezil—Alzheimer's disease	0.000436	0.00125	CcSEcCtD
Aprepitant—Syncope—Memantine—Alzheimer's disease	0.000435	0.00124	CcSEcCtD
Aprepitant—Infection—Donepezil—Alzheimer's disease	0.000433	0.00124	CcSEcCtD
Aprepitant—Shock—Donepezil—Alzheimer's disease	0.000429	0.00123	CcSEcCtD
Aprepitant—Palpitations—Memantine—Alzheimer's disease	0.000428	0.00123	CcSEcCtD
Aprepitant—Malaise—Rivastigmine—Alzheimer's disease	0.000427	0.00122	CcSEcCtD
Aprepitant—Nervous system disorder—Donepezil—Alzheimer's disease	0.000427	0.00122	CcSEcCtD
Aprepitant—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000426	0.00122	CcSEcCtD
Aprepitant—Loss of consciousness—Memantine—Alzheimer's disease	0.000426	0.00122	CcSEcCtD
Aprepitant—Syncope—Rivastigmine—Alzheimer's disease	0.000425	0.00122	CcSEcCtD
Aprepitant—Cough—Memantine—Alzheimer's disease	0.000423	0.00121	CcSEcCtD
Aprepitant—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000421	0.0012	CcSEcCtD
Aprepitant—Convulsion—Memantine—Alzheimer's disease	0.00042	0.0012	CcSEcCtD
Aprepitant—Palpitations—Rivastigmine—Alzheimer's disease	0.000419	0.0012	CcSEcCtD
Aprepitant—Hypertension—Memantine—Alzheimer's disease	0.000418	0.0012	CcSEcCtD
Aprepitant—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000417	0.00119	CcSEcCtD
Aprepitant—Anorexia—Donepezil—Alzheimer's disease	0.000415	0.00119	CcSEcCtD
Aprepitant—Hypersensitivity—Galantamine—Alzheimer's disease	0.000414	0.00118	CcSEcCtD
Aprepitant—Cough—Rivastigmine—Alzheimer's disease	0.000414	0.00118	CcSEcCtD
Aprepitant—Chest pain—Memantine—Alzheimer's disease	0.000413	0.00118	CcSEcCtD
Aprepitant—Arthralgia—Memantine—Alzheimer's disease	0.000413	0.00118	CcSEcCtD
Aprepitant—Myalgia—Memantine—Alzheimer's disease	0.000413	0.00118	CcSEcCtD
Aprepitant—Anxiety—Memantine—Alzheimer's disease	0.000411	0.00118	CcSEcCtD
Aprepitant—Convulsion—Rivastigmine—Alzheimer's disease	0.000411	0.00118	CcSEcCtD
Aprepitant—Hypertension—Rivastigmine—Alzheimer's disease	0.000409	0.00117	CcSEcCtD
Aprepitant—Discomfort—Memantine—Alzheimer's disease	0.000408	0.00117	CcSEcCtD
Aprepitant—Hypotension—Donepezil—Alzheimer's disease	0.000407	0.00116	CcSEcCtD
Aprepitant—Arthralgia—Rivastigmine—Alzheimer's disease	0.000404	0.00115	CcSEcCtD
Aprepitant—Myalgia—Rivastigmine—Alzheimer's disease	0.000404	0.00115	CcSEcCtD
Aprepitant—Chest pain—Rivastigmine—Alzheimer's disease	0.000404	0.00115	CcSEcCtD
Aprepitant—Dry mouth—Memantine—Alzheimer's disease	0.000403	0.00115	CcSEcCtD
Aprepitant—Asthenia—Galantamine—Alzheimer's disease	0.000403	0.00115	CcSEcCtD
Aprepitant—Anxiety—Rivastigmine—Alzheimer's disease	0.000402	0.00115	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000401	0.00115	CcSEcCtD
Aprepitant—Confusional state—Memantine—Alzheimer's disease	0.000399	0.00114	CcSEcCtD
Aprepitant—Discomfort—Rivastigmine—Alzheimer's disease	0.000399	0.00114	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000397	0.00114	CcSEcCtD
Aprepitant—Oedema—Memantine—Alzheimer's disease	0.000395	0.00113	CcSEcCtD
Aprepitant—Dry mouth—Rivastigmine—Alzheimer's disease	0.000395	0.00113	CcSEcCtD
Aprepitant—Insomnia—Donepezil—Alzheimer's disease	0.000394	0.00113	CcSEcCtD
Aprepitant—Infection—Memantine—Alzheimer's disease	0.000393	0.00112	CcSEcCtD
Aprepitant—Paraesthesia—Donepezil—Alzheimer's disease	0.000391	0.00112	CcSEcCtD
Aprepitant—Confusional state—Rivastigmine—Alzheimer's disease	0.00039	0.00112	CcSEcCtD
Aprepitant—Shock—Memantine—Alzheimer's disease	0.000389	0.00111	CcSEcCtD
Aprepitant—Dyspnoea—Donepezil—Alzheimer's disease	0.000388	0.00111	CcSEcCtD
Aprepitant—Nervous system disorder—Memantine—Alzheimer's disease	0.000388	0.00111	CcSEcCtD
Aprepitant—Somnolence—Donepezil—Alzheimer's disease	0.000387	0.00111	CcSEcCtD
Aprepitant—Thrombocytopenia—Memantine—Alzheimer's disease	0.000387	0.00111	CcSEcCtD
Aprepitant—Oedema—Rivastigmine—Alzheimer's disease	0.000387	0.00111	CcSEcCtD
Aprepitant—Tachycardia—Memantine—Alzheimer's disease	0.000386	0.0011	CcSEcCtD
Aprepitant—Diarrhoea—Galantamine—Alzheimer's disease	0.000385	0.0011	CcSEcCtD
Aprepitant—Infection—Rivastigmine—Alzheimer's disease	0.000384	0.0011	CcSEcCtD
Aprepitant—Skin disorder—Memantine—Alzheimer's disease	0.000384	0.0011	CcSEcCtD
Aprepitant—Dyspepsia—Donepezil—Alzheimer's disease	0.000383	0.0011	CcSEcCtD
Aprepitant—Hyperhidrosis—Memantine—Alzheimer's disease	0.000382	0.00109	CcSEcCtD
Aprepitant—Shock—Rivastigmine—Alzheimer's disease	0.000381	0.00109	CcSEcCtD
Aprepitant—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000379	0.00109	CcSEcCtD
Aprepitant—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000379	0.00108	CcSEcCtD
Aprepitant—Decreased appetite—Donepezil—Alzheimer's disease	0.000379	0.00108	CcSEcCtD
Aprepitant—Tachycardia—Rivastigmine—Alzheimer's disease	0.000378	0.00108	CcSEcCtD
Aprepitant—Anorexia—Memantine—Alzheimer's disease	0.000377	0.00108	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000376	0.00108	CcSEcCtD
Aprepitant—Skin disorder—Rivastigmine—Alzheimer's disease	0.000376	0.00108	CcSEcCtD
Aprepitant—Fatigue—Donepezil—Alzheimer's disease	0.000376	0.00107	CcSEcCtD
Aprepitant—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000374	0.00107	CcSEcCtD
Aprepitant—Pain—Donepezil—Alzheimer's disease	0.000372	0.00107	CcSEcCtD
Aprepitant—Constipation—Donepezil—Alzheimer's disease	0.000372	0.00107	CcSEcCtD
Aprepitant—Dizziness—Galantamine—Alzheimer's disease	0.000372	0.00106	CcSEcCtD
Aprepitant—Hypotension—Memantine—Alzheimer's disease	0.00037	0.00106	CcSEcCtD
Aprepitant—Anorexia—Rivastigmine—Alzheimer's disease	0.000369	0.00106	CcSEcCtD
Aprepitant—Hypotension—Rivastigmine—Alzheimer's disease	0.000362	0.00103	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00036	0.00103	CcSEcCtD
Aprepitant—Feeling abnormal—Donepezil—Alzheimer's disease	0.000359	0.00103	CcSEcCtD
Aprepitant—Insomnia—Memantine—Alzheimer's disease	0.000358	0.00102	CcSEcCtD
Aprepitant—Vomiting—Galantamine—Alzheimer's disease	0.000357	0.00102	CcSEcCtD
Aprepitant—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000356	0.00102	CcSEcCtD
Aprepitant—Paraesthesia—Memantine—Alzheimer's disease	0.000355	0.00102	CcSEcCtD
Aprepitant—Rash—Galantamine—Alzheimer's disease	0.000354	0.00101	CcSEcCtD
Aprepitant—Dermatitis—Galantamine—Alzheimer's disease	0.000354	0.00101	CcSEcCtD
Aprepitant—Dyspnoea—Memantine—Alzheimer's disease	0.000353	0.00101	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000352	0.00101	CcSEcCtD
Aprepitant—Headache—Galantamine—Alzheimer's disease	0.000352	0.00101	CcSEcCtD
Aprepitant—Somnolence—Memantine—Alzheimer's disease	0.000352	0.00101	CcSEcCtD
Aprepitant—Insomnia—Rivastigmine—Alzheimer's disease	0.00035	0.001	CcSEcCtD
Aprepitant—Dyspepsia—Memantine—Alzheimer's disease	0.000348	0.000996	CcSEcCtD
Aprepitant—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000347	0.000994	CcSEcCtD
Aprepitant—Urticaria—Donepezil—Alzheimer's disease	0.000346	0.00099	CcSEcCtD
Aprepitant—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000345	0.000987	CcSEcCtD
Aprepitant—Abdominal pain—Donepezil—Alzheimer's disease	0.000344	0.000985	CcSEcCtD
Aprepitant—Body temperature increased—Donepezil—Alzheimer's disease	0.000344	0.000985	CcSEcCtD
Aprepitant—Somnolence—Rivastigmine—Alzheimer's disease	0.000344	0.000984	CcSEcCtD
Aprepitant—Decreased appetite—Memantine—Alzheimer's disease	0.000344	0.000984	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000341	0.000977	CcSEcCtD
Aprepitant—Fatigue—Memantine—Alzheimer's disease	0.000341	0.000975	CcSEcCtD
Aprepitant—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000341	0.000974	CcSEcCtD
Aprepitant—Pain—Memantine—Alzheimer's disease	0.000338	0.000968	CcSEcCtD
Aprepitant—Constipation—Memantine—Alzheimer's disease	0.000338	0.000968	CcSEcCtD
Aprepitant—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000336	0.000962	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000334	0.000956	CcSEcCtD
Aprepitant—Nausea—Galantamine—Alzheimer's disease	0.000334	0.000955	CcSEcCtD
Aprepitant—Fatigue—Rivastigmine—Alzheimer's disease	0.000334	0.000954	CcSEcCtD
Aprepitant—Pain—Rivastigmine—Alzheimer's disease	0.000331	0.000947	CcSEcCtD
Aprepitant—Constipation—Rivastigmine—Alzheimer's disease	0.000331	0.000947	CcSEcCtD
Aprepitant—Feeling abnormal—Memantine—Alzheimer's disease	0.000326	0.000932	CcSEcCtD
Aprepitant—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000323	0.000925	CcSEcCtD
Aprepitant—Hypersensitivity—Donepezil—Alzheimer's disease	0.000321	0.000918	CcSEcCtD
Aprepitant—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000319	0.000912	CcSEcCtD
Aprepitant—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000316	0.000905	CcSEcCtD
Aprepitant—Urticaria—Memantine—Alzheimer's disease	0.000314	0.000899	CcSEcCtD
Aprepitant—Abdominal pain—Memantine—Alzheimer's disease	0.000313	0.000894	CcSEcCtD
Aprepitant—Body temperature increased—Memantine—Alzheimer's disease	0.000313	0.000894	CcSEcCtD
Aprepitant—Asthenia—Donepezil—Alzheimer's disease	0.000313	0.000894	CcSEcCtD
Aprepitant—Pruritus—Donepezil—Alzheimer's disease	0.000308	0.000882	CcSEcCtD
Aprepitant—Urticaria—Rivastigmine—Alzheimer's disease	0.000307	0.000879	CcSEcCtD
Aprepitant—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000306	0.000875	CcSEcCtD
Aprepitant—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000306	0.000875	CcSEcCtD
Aprepitant—Diarrhoea—Donepezil—Alzheimer's disease	0.000298	0.000853	CcSEcCtD
Aprepitant—Hypersensitivity—Memantine—Alzheimer's disease	0.000291	0.000834	CcSEcCtD
Aprepitant—Dizziness—Donepezil—Alzheimer's disease	0.000288	0.000824	CcSEcCtD
Aprepitant—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000285	0.000815	CcSEcCtD
Aprepitant—Asthenia—Memantine—Alzheimer's disease	0.000284	0.000812	CcSEcCtD
Aprepitant—Pruritus—Memantine—Alzheimer's disease	0.00028	0.0008	CcSEcCtD
Aprepitant—Asthenia—Rivastigmine—Alzheimer's disease	0.000278	0.000794	CcSEcCtD
Aprepitant—Vomiting—Donepezil—Alzheimer's disease	0.000277	0.000792	CcSEcCtD
Aprepitant—Rash—Donepezil—Alzheimer's disease	0.000275	0.000786	CcSEcCtD
Aprepitant—Dermatitis—Donepezil—Alzheimer's disease	0.000274	0.000785	CcSEcCtD
Aprepitant—Pruritus—Rivastigmine—Alzheimer's disease	0.000274	0.000783	CcSEcCtD
Aprepitant—Headache—Donepezil—Alzheimer's disease	0.000273	0.000781	CcSEcCtD
Aprepitant—Diarrhoea—Memantine—Alzheimer's disease	0.000271	0.000774	CcSEcCtD
Aprepitant—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000265	0.000757	CcSEcCtD
Aprepitant—Dizziness—Memantine—Alzheimer's disease	0.000262	0.000748	CcSEcCtD
Aprepitant—Nausea—Donepezil—Alzheimer's disease	0.000259	0.00074	CcSEcCtD
Aprepitant—Dizziness—Rivastigmine—Alzheimer's disease	0.000256	0.000732	CcSEcCtD
Aprepitant—Vomiting—Memantine—Alzheimer's disease	0.000251	0.000719	CcSEcCtD
Aprepitant—Rash—Memantine—Alzheimer's disease	0.000249	0.000713	CcSEcCtD
Aprepitant—Dermatitis—Memantine—Alzheimer's disease	0.000249	0.000713	CcSEcCtD
Aprepitant—Headache—Memantine—Alzheimer's disease	0.000248	0.000709	CcSEcCtD
Aprepitant—Vomiting—Rivastigmine—Alzheimer's disease	0.000246	0.000704	CcSEcCtD
Aprepitant—Rash—Rivastigmine—Alzheimer's disease	0.000244	0.000698	CcSEcCtD
Aprepitant—Dermatitis—Rivastigmine—Alzheimer's disease	0.000244	0.000697	CcSEcCtD
Aprepitant—Headache—Rivastigmine—Alzheimer's disease	0.000242	0.000693	CcSEcCtD
Aprepitant—Nausea—Memantine—Alzheimer's disease	0.000235	0.000672	CcSEcCtD
Aprepitant—Nausea—Rivastigmine—Alzheimer's disease	0.00023	0.000657	CcSEcCtD
Aprepitant—CYP3A5—Metabolism—ND1—Alzheimer's disease	4.36e-05	0.000335	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MEF2C—Alzheimer's disease	4.35e-05	0.000335	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.35e-05	0.000334	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PRKCG—Alzheimer's disease	4.27e-05	0.000328	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GAPDHS—Alzheimer's disease	4.18e-05	0.000322	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NGF—Alzheimer's disease	4.16e-05	0.00032	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	4.08e-05	0.000314	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—VEGFA—Alzheimer's disease	4.07e-05	0.000313	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CA4—Alzheimer's disease	4.06e-05	0.000312	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCR5—Alzheimer's disease	4.05e-05	0.000311	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ATP5A1—Alzheimer's disease	3.97e-05	0.000305	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	3.97e-05	0.000305	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HTR2A—Alzheimer's disease	3.96e-05	0.000304	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—TPI1—Alzheimer's disease	3.89e-05	0.000299	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CHAT—Alzheimer's disease	3.89e-05	0.000299	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	3.81e-05	0.000293	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	3.8e-05	0.000292	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PLD3—Alzheimer's disease	3.78e-05	0.000291	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.78e-05	0.000291	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.74e-05	0.000288	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TGFB1—Alzheimer's disease	3.73e-05	0.000287	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—MAOB—Alzheimer's disease	3.73e-05	0.000287	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CALM1—Alzheimer's disease	3.69e-05	0.000284	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—LEP—Alzheimer's disease	3.68e-05	0.000283	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—APOE—Alzheimer's disease	3.68e-05	0.000283	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CAV1—Alzheimer's disease	3.65e-05	0.00028	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HSD17B10—Alzheimer's disease	3.63e-05	0.000279	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	3.62e-05	0.000278	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GAPDH—Alzheimer's disease	3.59e-05	0.000276	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.55e-05	0.000273	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ESR1—Alzheimer's disease	3.51e-05	0.00027	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	3.49e-05	0.000269	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—F2—Alzheimer's disease	3.47e-05	0.000267	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CA4—Alzheimer's disease	3.47e-05	0.000267	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—A2M—Alzheimer's disease	3.47e-05	0.000267	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PLD3—Alzheimer's disease	3.45e-05	0.000265	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.45e-05	0.000265	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.41e-05	0.000262	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NOTCH1—Alzheimer's disease	3.4e-05	0.000261	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	3.39e-05	0.000261	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ND1—Alzheimer's disease	3.37e-05	0.000259	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	3.31e-05	0.000254	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.3e-05	0.000253	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	3.26e-05	0.000251	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.23e-05	0.000249	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—GSK3B—Alzheimer's disease	3.19e-05	0.000245	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	3.18e-05	0.000245	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CREB1—Alzheimer's disease	3.16e-05	0.000243	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	3.15e-05	0.000242	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—INS—Alzheimer's disease	3.14e-05	0.000242	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCL2—Alzheimer's disease	3.09e-05	0.000238	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	3.09e-05	0.000238	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ND1—Alzheimer's disease	3.07e-05	0.000236	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TP53—Alzheimer's disease	3.07e-05	0.000236	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IGF1—Alzheimer's disease	3.04e-05	0.000234	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ACHE—Alzheimer's disease	3.02e-05	0.000232	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.01e-05	0.000232	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.01e-05	0.000231	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—INPP5D—Alzheimer's disease	2.98e-05	0.000229	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PLD3—Alzheimer's disease	2.95e-05	0.000227	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.95e-05	0.000227	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.91e-05	0.000224	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	2.83e-05	0.000217	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ENO1—Alzheimer's disease	2.83e-05	0.000217	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS1—Alzheimer's disease	2.83e-05	0.000217	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL6—Alzheimer's disease	2.81e-05	0.000216	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CHAT—Alzheimer's disease	2.81e-05	0.000216	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—TPI1—Alzheimer's disease	2.81e-05	0.000216	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP2D6—Alzheimer's disease	2.77e-05	0.000213	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.76e-05	0.000212	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NOS3—Alzheimer's disease	2.76e-05	0.000212	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.75e-05	0.000211	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	2.72e-05	0.000209	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—MAOB—Alzheimer's disease	2.69e-05	0.000207	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.68e-05	0.000206	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ND1—Alzheimer's disease	2.63e-05	0.000202	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—BCHE—Alzheimer's disease	2.63e-05	0.000202	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.6e-05	0.0002	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—AKT1—Alzheimer's disease	2.6e-05	0.0002	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GAPDH—Alzheimer's disease	2.59e-05	0.000199	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.57e-05	0.000198	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.52e-05	0.000193	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—A2M—Alzheimer's disease	2.51e-05	0.000193	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PLCB1—Alzheimer's disease	2.48e-05	0.000191	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ABCA1—Alzheimer's disease	2.4e-05	0.000185	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.39e-05	0.000183	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.37e-05	0.000182	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.37e-05	0.000182	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.36e-05	0.000182	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.35e-05	0.000181	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CASP3—Alzheimer's disease	2.34e-05	0.00018	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL6—Alzheimer's disease	2.33e-05	0.000179	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.28e-05	0.000175	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	2.18e-05	0.000168	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ACHE—Alzheimer's disease	2.18e-05	0.000168	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CHAT—Alzheimer's disease	2.17e-05	0.000167	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—TPI1—Alzheimer's disease	2.17e-05	0.000167	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.16e-05	0.000166	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	2.15e-05	0.000166	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MAPK8—Alzheimer's disease	2.15e-05	0.000165	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—AKT1—Alzheimer's disease	2.15e-05	0.000165	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	2.1e-05	0.000161	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MAOB—Alzheimer's disease	2.08e-05	0.00016	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PPARGC1A—Alzheimer's disease	2.07e-05	0.000159	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—HMOX1—Alzheimer's disease	2.06e-05	0.000159	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ENO1—Alzheimer's disease	2.04e-05	0.000157	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	2.04e-05	0.000157	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ND1—Alzheimer's disease	2.03e-05	0.000156	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.02e-05	0.000156	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	2.01e-05	0.000154	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	2e-05	0.000154	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—VEGFA—Alzheimer's disease	1.99e-05	0.000153	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.98e-05	0.000152	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.98e-05	0.000152	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.98e-05	0.000152	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.96e-05	0.000151	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—A2M—Alzheimer's disease	1.94e-05	0.000149	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.9e-05	0.000146	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—BCHE—Alzheimer's disease	1.9e-05	0.000146	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—LPL—Alzheimer's disease	1.89e-05	0.000145	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.84e-05	0.000142	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1.83e-05	0.000141	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TGFB1—Alzheimer's disease	1.82e-05	0.00014	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.81e-05	0.000139	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	1.79e-05	0.000138	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.79e-05	0.000138	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—A2M—Alzheimer's disease	1.77e-05	0.000136	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	1.74e-05	0.000134	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.73e-05	0.000133	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—MTHFR—Alzheimer's disease	1.7e-05	0.000131	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—TPI1—Alzheimer's disease	1.69e-05	0.00013	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CHAT—Alzheimer's disease	1.69e-05	0.00013	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ACHE—Alzheimer's disease	1.69e-05	0.00013	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	1.67e-05	0.000128	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MAOB—Alzheimer's disease	1.62e-05	0.000125	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CALM1—Alzheimer's disease	1.59e-05	0.000122	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—APOE—Alzheimer's disease	1.58e-05	0.000122	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	1.58e-05	0.000121	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ENO1—Alzheimer's disease	1.58e-05	0.000121	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.57e-05	0.000121	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CAV1—Alzheimer's disease	1.57e-05	0.00012	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	1.56e-05	0.00012	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	1.55e-05	0.000119	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.55e-05	0.000119	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ACHE—Alzheimer's disease	1.54e-05	0.000118	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.53e-05	0.000118	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	1.52e-05	0.000117	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—A2M—Alzheimer's disease	1.51e-05	0.000116	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TP53—Alzheimer's disease	1.5e-05	0.000115	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	1.5e-05	0.000115	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	1.49e-05	0.000115	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—BCHE—Alzheimer's disease	1.47e-05	0.000113	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ENO1—Alzheimer's disease	1.44e-05	0.000111	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	1.44e-05	0.000111	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	1.41e-05	0.000109	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	1.39e-05	0.000107	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PPARG—Alzheimer's disease	1.38e-05	0.000106	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL6—Alzheimer's disease	1.37e-05	0.000106	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—LPL—Alzheimer's disease	1.36e-05	0.000105	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.36e-05	0.000104	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—INS—Alzheimer's disease	1.35e-05	0.000104	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.35e-05	0.000103	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	1.34e-05	0.000103	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—BCHE—Alzheimer's disease	1.34e-05	0.000103	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ACHE—Alzheimer's disease	1.31e-05	0.000101	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.31e-05	0.0001	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.31e-05	0.0001	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	1.3e-05	9.98e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—AKT1—Alzheimer's disease	1.27e-05	9.75e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	1.26e-05	9.71e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.25e-05	9.63e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.24e-05	9.53e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ENO1—Alzheimer's disease	1.23e-05	9.46e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	1.23e-05	9.46e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	1.23e-05	9.44e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	1.22e-05	9.41e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	1.21e-05	9.28e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.21e-05	9.27e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—NOS3—Alzheimer's disease	1.18e-05	9.1e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.16e-05	8.96e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	1.16e-05	8.9e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	1.15e-05	8.86e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CALM1—Alzheimer's disease	1.15e-05	8.81e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—BCHE—Alzheimer's disease	1.14e-05	8.8e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—APOE—Alzheimer's disease	1.14e-05	8.78e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CAV1—Alzheimer's disease	1.13e-05	8.7e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	1.08e-05	8.33e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	1.08e-05	8.3e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.06e-05	8.14e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	1.06e-05	8.11e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—LPL—Alzheimer's disease	1.05e-05	8.1e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	1.05e-05	8.08e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	1.05e-05	8.04e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.01e-05	7.79e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1e-05	7.7e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARG—Alzheimer's disease	9.95e-06	7.65e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—INS—Alzheimer's disease	9.76e-06	7.5e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—LPL—Alzheimer's disease	9.61e-06	7.39e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ENO1—Alzheimer's disease	9.49e-06	7.3e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	9.49e-06	7.3e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	9.49e-06	7.29e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	9.31e-06	7.16e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	9.02e-06	6.93e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	8.98e-06	6.9e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CALM1—Alzheimer's disease	8.86e-06	6.81e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—APOE—Alzheimer's disease	8.83e-06	6.79e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—BCHE—Alzheimer's disease	8.83e-06	6.79e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CAV1—Alzheimer's disease	8.75e-06	6.73e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	8.65e-06	6.65e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NOS3—Alzheimer's disease	8.56e-06	6.58e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	8.33e-06	6.41e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LPL—Alzheimer's disease	8.21e-06	6.31e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CALM1—Alzheimer's disease	8.08e-06	6.21e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	8.07e-06	6.21e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOE—Alzheimer's disease	8.05e-06	6.19e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CAV1—Alzheimer's disease	7.98e-06	6.14e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	7.83e-06	6.02e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARG—Alzheimer's disease	7.69e-06	5.92e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—INS—Alzheimer's disease	7.54e-06	5.8e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	7.39e-06	5.68e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARG—Alzheimer's disease	7.01e-06	5.39e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	6.96e-06	5.35e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	6.93e-06	5.33e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CALM1—Alzheimer's disease	6.91e-06	5.31e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOE—Alzheimer's disease	6.88e-06	5.29e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—INS—Alzheimer's disease	6.88e-06	5.29e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CAV1—Alzheimer's disease	6.82e-06	5.24e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NOS3—Alzheimer's disease	6.62e-06	5.09e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LPL—Alzheimer's disease	6.34e-06	4.87e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	6.05e-06	4.65e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NOS3—Alzheimer's disease	6.03e-06	4.64e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARG—Alzheimer's disease	5.99e-06	4.61e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—INS—Alzheimer's disease	5.88e-06	4.52e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	5.7e-06	4.39e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	5.52e-06	4.24e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AKT1—Alzheimer's disease	5.44e-06	4.18e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CALM1—Alzheimer's disease	5.33e-06	4.1e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOE—Alzheimer's disease	5.31e-06	4.08e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CAV1—Alzheimer's disease	5.26e-06	4.05e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NOS3—Alzheimer's disease	5.15e-06	3.96e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	4.71e-06	3.63e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARG—Alzheimer's disease	4.63e-06	3.56e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—INS—Alzheimer's disease	4.54e-06	3.49e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.98e-06	3.06e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AKT1—Alzheimer's disease	3.93e-06	3.03e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	3.64e-06	2.8e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AKT1—Alzheimer's disease	3.04e-06	2.34e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AKT1—Alzheimer's disease	2.77e-06	2.13e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AKT1—Alzheimer's disease	2.37e-06	1.82e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.83e-06	1.41e-05	CbGpPWpGaD
